TGF-β signalling defect is linked to low CD39 expression on regulatory T cells and methotrexate resistance in rheumatoid arthritis. (Q50092867)
Jump to navigation
Jump to search
scientific article published on 6 February 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | TGF-β signalling defect is linked to low CD39 expression on regulatory T cells and methotrexate resistance in rheumatoid arthritis. |
scientific article published on 6 February 2018 |
Statements
TGF-β signalling defect is linked to low CD39 expression on regulatory T cells and methotrexate resistance in rheumatoid arthritis (English)
Foo Y Liew
Thiago M Cunha
Fernando Q Cunha
Raphael S Peres
José Carlos Alves-Filho
Jhimmy Talbot
Rene D Oliveira
Kalil W A Lima
Patricia R Lobo